Michaela Frey

IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype

M. Theobald, W. Herr, D. Teschner, 2011, Cancer Immunology, Immunotherapy.

Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis

S. Thomas, M. Theobald, W. Herr, 2014, Bone Marrow Transplantation.

Alloreactive and leukemia-reactive T cells are preferentially derived from naïve precursors in healthy donors: implications for immunotherapy with memory T cells

M. Theobald, Alexander Hohberger, W. Herr, 2011, Haematologica.

Patient‐individualized CD8+ cytolytic T‐cell therapy effectively combats minimal residual leukemia in immunodeficient mice

Shamsul A. Khan, A. Mottok, A. Beilhack, 2016, International journal of cancer.